The outbreak of coronavirus disease 2019 (COVID-19) in December 2019 has rapidly spread globally with significant negative impact on health. There is an urgent need for a drug or vaccine certified for treating and preventing COVID-19 respectively. Tocilizumab, an interleukin-6 monoclonal receptor antibody, has been used in some centers for mitigating the severe inflammatory response seen in patients with severe COVID-19 with encouraging results. To the best of our knowledge, reports detailing the outcomes of patients with severe COVID-19 undergoing treatment with tocilizumab are sparse in sub-Saharan Africa. We describe the clinical and laboratory profile, chest Computed Tomography (CT) scan findings and clinical outcome in a Ghanaian patient with severe COVID-19 pneumonia treated with tocilizumab. A 54-year-old hypertensive male presented with fever, productive cough, pleuritic chest pain and breathlessness. He tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by polymerase chain reaction analysis done on a nasopharyngeal swab sample. His respiratory symptoms worsened while on admission despite receiving standard of care. His C-reactive protein (CRP) was elevated to 80.59mg/L and chest CT scan findings were indicative of severe COVID-19 pneumonia. He was treated with a single 400mg dose of intravenous tocilizumab with a positive clinical outcome, rapid decline in CRP and improvement in chest CT findings. Our experience shows that tocilizumab shows great promise as drug therapy for COVID-19 pneumonia.
【저자키워드】 COVID-19, Tocilizumab, interleukin-6, Case report, sub-Saharan Africa, 【초록키워드】 coronavirus disease, SARS-CoV-2, Coronavirus disease 2019, Vaccine, Severe COVID-19 pneumonia, coronavirus, COVID-19 pneumonia, severe COVID-19, Tocilizumab, Pneumonia, antibody, knowledge, interleukin-6, C-reactive protein, CRP, drug, outcome, severe acute respiratory syndrome Coronavirus, cough, drug therapy, Laboratory, Clinical outcome, Spread, Computed tomography, Nasopharyngeal swab, polymerase chain reaction, Health, Chest CT, outbreak, sub-Saharan Africa, Chest, Fever, male, Patient, receptor, respiratory, Admission, monoclonal, Inflammatory response, Analysis, dose, chest CT scan, chest pain, respiratory symptoms, best, on admission, in some, Chain Reaction, C-reactive protein (CRP, productive cough, Standard of care, breathlessness, acute respiratory syndrome, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, hypertensive, respiratory symptom, positive, intravenous tocilizumab, nasopharyngeal swab sample, polymerase chain, tested, elevated, receiving, treated, pleuritic, therapy for COVID-19, treatment with tocilizumab, worsened, 【제목키워드】 Tocilizumab, Patient, Teaching,